Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA rece... MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0499 | 5.25207872855 | 0.9501 | 1.01 | 0.902 | 112287 | 0.96638507 | CS |
| 4 | -0.06 | -5.66037735849 | 1.06 | 1.09 | 0.902 | 103965 | 0.98490625 | CS |
| 12 | -0.08 | -7.40740740741 | 1.08 | 1.2 | 0.902 | 127175 | 1.03242319 | CS |
| 26 | -0.5 | -33.3333333333 | 1.5 | 1.54 | 0.9001 | 142384 | 1.15103649 | CS |
| 52 | -0.25 | -20 | 1.25 | 2.45 | 0.9001 | 1185155 | 1.53445928 | CS |
| 156 | -6 | -85.7142857143 | 7 | 7.9799 | 0.51 | 1255639 | 2.26904659 | CS |
| 260 | -6 | -85.7142857143 | 7 | 7.9799 | 0.51 | 1255639 | 2.26904659 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
